Heterotopic bicaval implantation effectively improved chronic heart failure and induced positive reverse right ventricular remodeling in a high-risk patient over 12 months.
Does heterotopic bicaval implantation of a transcatheter valve system improve heart failure control and right ventricular remodeling in a high-risk patient with severe tricuspid regurgitation?
Heterotopic bicaval implantation of a transcatheter valve system may be an effective option for severe tricuspid regurgitation in patients with prohibitive surgical risk and unsuitable anatomy for edge-to-edge repair.
Tasa de eventos absoluta: 0% vs 0%
The authors describe the first case of heterotopic bicaval implantation of transcatheter valve system in Russia for correction of severe tricuspid regurgitation in a patient with extremely high surgical risk and contraindication for redo surgery under cardiopulmonary bypass. The patient did not meet anatomical criteria for transcatheter edge-to-edge tricuspid valve repair. This case demonstrates the effectiveness of heterotopic bicaval implantation for tricuspid valve disease in high-risk patient with better control of chronic heart failure and positive reverse right ventricular remodeling over a 12-month follow-up.
Imaev et al. (Tue,) reported a other. Heterotopic bicaval implantation effectively improved chronic heart failure and induced positive reverse right ventricular remodeling in a high-risk patient over 12 months.